Pervasis Therapeutics Lands $12,000,000 Series B Financing Round

  • Feed Type
  • Date
  • Company Name
    Pervasis Therapeutics
  • Mailing Address
    One Kendall Square, Building 600 Cambridge, MA 02139
  • Company Description
    Pervasis Therapeutics is focused on creating biologically active vascular technologies to treat significant unmet needs in cardiovascular disease.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    The financing will be used to continue clinical development of the company’s first product, a combination device for patients with vascular disease.
  • M&A Terms
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor
    Highland Capital Partners
  • Venture Investor
    Flagship Ventures

Trending on Xconomy